Site search

Clear filter
2903 results for '' found
YKP509C003 Protocol: A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Carisbamate [YKP509] as Adjunctive Treatment for Seizures Associated With Lenno
YKP509C003 Protocol: A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Carisbamate [YKP509] as Adjunctive Treatment for Seizures Associated With Lenno
/
Phase 2/3, Multistage, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel Group Withdrawal Study to Evaluate the Efficacy and Safety of Nipocalimab Administered to Adults with Chr
Phase 2/3, Multistage, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel Group Withdrawal Study to Evaluate the Efficacy and Safety of Nipocalimab Administered to Adults with Chr
/
A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-Tumor Activity of Subcutaneous Tarlatamab in Subjects with Extensive Stage Small Cell Lung Cancer [DeL
/
Discovery, design, and analysis of novel allergen peptide therapeutics (Trial Not Registered)
Discovery, design, and analysis of novel allergen peptide therapeutics (Trial Not Registered)
/
Efficacy and Safety of Concizumab prophylaxis in patients with haemophilia A or B with inhibitors [Explorer 7]
Efficacy and Safety of Concizumab prophylaxis in patients with haemophilia A or B with inhibitors [Explorer 7]
/
Outcomes of redo atrial fibrillation ablation with posterior wall isolation in patients with enduring pulmonary vein isolation (Trial Not Registered)
Outcomes of redo atrial fibrillation ablation with posterior wall isolation in patients with enduring pulmonary vein isolation (Trial Not Registered)
/
Treatment of Stroke Recurrence in CAA with Tranexamic Acid (ACTRN12624001477516)
Treatment of Stroke Recurrence in CAA with Tranexamic Acid (ACTRN12624001477516)
/
A Phase 2, Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous NVG-2089 in Participants with Chronic Inflammatory Demyelinating Polyneuropathy [CIDP]
A Phase 2, Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous NVG-2089 in Participants with Chronic Inflammatory Demyelinating Polyneuropathy [CIDP]
/
A non-interventional research study of the alterations in the microbiome in inflammatory skin disease (Trial Not Registered)
A non-interventional research study of the alterations in the microbiome in inflammatory skin disease (Trial Not Registered)
/
A Multicenter, Open-label, Long-term, Safety, Tolerability, and Efficacy Study of XEN1101 in Adults Diagnosed With Epilepsy
A Multicenter, Open-label, Long-term, Safety, Tolerability, and Efficacy Study of XEN1101 in Adults Diagnosed With Epilepsy
/
4 5 6 7 8